FDA Approves Eli Lilly’s Alzheimer’s Drug That Slows Memory Decline
The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking skills in people with the disease, the drugmaker said Tuesday. The drug donanemab, which will be sold under the brand name Kisunla, is an infusion of … Read more